<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1235">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00796380</url>
  </required_header>
  <id_info>
    <org_study_id>ChiCTR-TNC-00000097</org_study_id>
    <nct_id>NCT00796380</nct_id>
  </id_info>
  <brief_title>Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases</brief_title>
  <official_title>Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shenzhen Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shenzhen Children's Hospital</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of
      convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated
      by Xingnaojing and the role inflammation plays in the process.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">July 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Antipyretic rate , Frequency of convulsive episodes ,</measure>
    <time_frame>one year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of convulsive episodes</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1</enrollment>
  <condition>Convulsive Diseases</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xingnaojing</intervention_name>
    <description>injection</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Febrile convulsion: positive family history of febrile convulsion; aged between 6
             months and 6 years old; in accordance with the diagnosis criteria of simple type of
             febrile convulsion

          2. Frequent episodes of epilepsy: epilepsy episodes of all types; &gt; 3 times / week

          3. Refractory epilepsy: no satisfactory efficacy after treatment by 2~3 antiepileptic
             drugs; â‰¥ 1 time / month

          4. Cerebral palsy: all types of cerebral palsy in children less than 3 years old. -

        Exclusion Criteria:

          1. Febrile convulsion: family history of epilepsy, complex type of febrile convulsion,
             epileptic episodes, febrile convulsion plus

          2. Frequent episodes of epilepsy: combined with advanced diseases

          3. Refractory epilepsy: epilepsy combined with advanced diseases

          4. Cerebral palsy: advanced diseases combined with backwardness or retardation of brain
             function development.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2008</verification_date>
  <lastchanged_date>November 21, 2008</lastchanged_date>
  <firstreceived_date>November 21, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Epilepsy and cerebral palsy center, Shenzhen Children's Hospital</name_title>
    <organization>Shenzhen Children's Hospital</organization>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
